Pharmacological Options in Heart Failure 1 & 2

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/21

flashcard set

Earn XP

Description and Tags

M.10, W.2, L.8+9

Last updated 2:27 PM on 5/25/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

22 Terms

1
New cards

List the 4 different drug classes used for heart failure

  • Sympathomimetics

  • Diuretics

  • Vasodilators

  • Inodilators

2
New cards

Define Sympathomimetics

drugs that stimulate the sympathetic nervous system, mainly through B1-adrenoreceptors in the heart

3
New cards

Describe the MOA for Sympathomimetics

B1 receptor stimulation activates adenylate cyclase through a G-protein:

B1 receptor activation↑ cAMP↑Ca2+↑cardiaccontractility

This leads to:

  • increased intracellular Ca2+

  • increased force of contraction (positive inotropy)

  • Increased heart rate (positive chronotropy)

4
New cards

Describe the G-protein-coupled receptor and cAMP pathway and how that leads to increased intracellular Ca2+ for sympathomimetics

  • Drug or hormone binds to B1-adrenoreceptor on cardiac muscle cells

    • B1-adrenoreceptors activated by sympathetic neurotransmitters

      • Adrenaline (epinephrine)

      • Noradrenaline (norepinephrine)

  • Binding activates g-protein dissociation

  • G-protein binds to adenylate cyclase and activates it

  • adenylate cyclase converts ATP to cAMP

  • cAMP acts as secondary messenger inside the cell and activates protein kinase A (PKA)

  • PKA causes calcium channels to open and Ca2+ enters the cardiac cell

    • Sarcoplasmic reticulum also releases calcium

  • More Ca2+ = Increase force of contraction

  • Final result: Increased cardiac contractility

<ul><li><p>Drug or hormone binds to B1-adrenoreceptor on <strong>cardiac muscle cells</strong></p><ul><li><p>B1-adrenoreceptors activated by <strong>sympathetic neurotransmitters</strong></p><ul><li><p>Adrenaline (epinephrine)</p></li><li><p>Noradrenaline (norepinephrine)</p></li></ul></li></ul></li><li><p>Binding activates g-protein dissociation</p></li><li><p>G-protein binds to adenylate cyclase and activates it</p></li><li><p>adenylate cyclase converts ATP to cAMP</p></li><li><p>cAMP acts as secondary messenger inside the cell and activates <strong>protein kinase A </strong>(PKA) </p></li><li><p>PKA causes calcium channels to open and Ca2+ enters the cardiac cell</p><ul><li><p>Sarcoplasmic reticulum also releases calcium</p></li></ul></li><li><p>More Ca2+ = Increase force of contraction</p></li><li><p>Final result: <strong>Increased cardiac contractility</strong></p></li></ul><p></p>
5
New cards

List an example of a synthetic B1-agonist and when it’s used

  • Dobutamine

    • used short term in severe acute heart failure with poor systolic function

6
New cards

List limitations and adverse effects of Sympathomimetics

  • Catecholamines can also stimulate a-receptors causing:

    • vasoconstriction

    • tachycardia

    • arrhythmias

  • Long-term use may down-regulate B-receptors, reducing effectiveness

7
New cards

What do diuretics do?

  • Increase:

    • urine production (diuresis)

    • sodium excretion (natriuresis)

  • reduce fluid overload and edema in heart failure

8
New cards

List the 5 types of diuretics

  • Loop Diuretics

  • Thiazide Diuretics

  • Potassium-sparing Diuretics

  • Other Diuretics:

    • Osmotic Diuretics

    • Carbonic Anhydrase Inhibitors

9
New cards

List examples, MOA and adverse effects of Loop Diuretics

Examples

  • furosemide

  • torasemide

MOA

  • Act in the thick ascending limb of the loop of Henle by inhibiting the Na+/K+/2Cl- cotransporter:

    • Na+/K+/2Cl- transporter inhibitionIncreased Na+, K+, Cl- excretionIncreased waterloss

    • This decreases medullary osmolarity and reduces water reabsorption

Adverse Effects

  • dehydration

  • electrolyte loss

  • pre-renal azotemia

  • ototoxicity at high doses

10
New cards

List two examples of Potassium-sparing diuretics

  • Amiloride

  • Spironolactone

11
New cards

Define Amiloride (type of diuretic, MOA)

  • weak diuretic

  • MOA

    • reduces epithelial Na+ channels in collecting tubule

    • reduces K+ loss

12
New cards

Define Spironolactone (type of medication, MOA)

  • competitive aldosterone antagonist

    • (reduces action of aldosterone)

  • prevents Na+ and water retention

  • helps prevent “aldosterone escape”

13
New cards

What is the clinical importance of potassium-sparing diuretics?

combined with loop diuretics to reduce hypokalemia and improve survivial

14
New cards

What do vasodilators do?

Reduce:

  • preload

  • afterload

  • cardiac workload (“unloading the failing heart”)

15
New cards

List the 5 types of Vasodilators

  • Calcium channel blockers

  • a1-adrenoreceptor antagonists

  • Nitrates

  • ACE Inhibitors

  • Angiotensin II Receptor Blockers (ARBs)

16
New cards

Describe Calcium Channel Blockers (Classes and MOA)

Classes

  • Verapamil → mainly cardiac effects

  • Amlodipine → mainly vascular dilation

  • Diltiazem → intermediate effects

MOA

  • Block L-type calcium channels

    • relaxes blood vessels

    • decreases heart contractility

    • slows heart rate

17
New cards

Describe a1-adrenoreceptor antagonists (example, MOA, adverse effects)

Example

  • Prazosin

MOA

  • block a1-receptors

    • causing vasodilation and reduced peripheral resistance

Adverse Effects

  • hypotension

  • syncope

18
New cards

Describe Nitrates (example, MOA, adverse effects)

Example

  • Glyceryl trinitrate

MOA

  • Donate nitric oxide (NO), producing vasodilation:

    • NO Increased cGMPvascular smooth muscle relaxation

Adverse Effects

  • hypotension

  • syncope

19
New cards

Describe ACE Inhibitors (example, MOA + effects, adverse effects)

Example

  • Enalapril

  • Benazepril

  • Ramipril

MOA

  • Block conversion of angiotensin I to angiotensin II:

    • ACE inhibition Decreased Angiotensin IIvasodilation + decreased aldosterone

      • arteriolar and venous dilation

      • reduced aldosterone

      • increased Na+ and water excretion

      • reduced edema

      • increased bradykinin-mediated vasodilation

Adverse Effects

  • hypotension

  • hyperkalemia

  • renal impairment

20
New cards
21
New cards
22
New cards